BioXcel Therapeutics, Inc. (19)

Browse by Contract Category

Contracts

Separation Agreement and General Release between Reina Benabou and BioXcel Therapeutics, Inc., dated July 28, 2021 (Filed With SEC on August 10, 2021)
Underwriting Agreement, dated June 22, 2021, among the Company, the Selling Stockholder and BofA Securities, Inc., as representative of the underwriters named therein (Filed With SEC on June 25, 2021)
Open Market Sale Agreement, dated as of May 10, 2021, by and between BioXcel Therapeutics, Inc. and Jefferies LLC (Filed With SEC on May 10, 2021)
First Amendment, dated August 19, 2020, to Lease Agreement, dated as of August 20, 2018, by and between Fusco Harbour Associates, LLC, as Landlord, and BioXcel Therapeutics, Inc.,... (Filed With SEC on November 12, 2020)
Employment Agreement between Javier Rodriguez and BioXcel Therapeutics, Inc., dated February 15, 2021 (Filed With SEC on March 12, 2021)
First Amendment to Second Amended and Restated Separation and Shared Services Agreement, dated March 3, 2021, by and between BioXcel LLC and BioXcel Therapeutics Inc (Filed With SEC on March 12, 2021)
BioXcel Therapeutics, Inc. 2020 Incentive Award Plan and forms of award agreements thereunder (Filed With SEC on August 14, 2020)
Employment Agreement between Reina Benabou and BioXcel Therapeutics, Inc., dated June 21, 2020 (Filed With SEC on August 14, 2020)
Employment Agreement between William Kane and BioXcel Therapeutics, Inc., dated May 15, 2020 (Filed With SEC on August 14, 2020)
Underwriting Agreement, dated July 28, 2020, among the Company, the Selling Stockholders and BofA Securities, Inc., as representative of the underwriters named therein (Filed With SEC on July 31, 2020)
BioXcel Therapeutics, Inc. 2020 Employee Stock Purchase Plan (Filed With SEC on May 21, 2020)
BioXcel Therapeutics, Inc. 2020 Incentive Award Plan (Filed With SEC on May 21, 2020)
Non-Employee Director Compensation Program (Filed With SEC on May 12, 2020)
Second Amended and Restated Separation and Shared Services Agreement, dated March 6, 2020, by and between BioXcel Corporation and BioXcel Therapeutics, Inc (Filed With SEC on March 9, 2020)
Description of the Registrants Securities Registered Under Section 12 of the Exchange Act (Filed With SEC on March 9, 2020)
Purchase Agreement, dated February 18, 2020, among the Company and BioXcel Corporation (Filed With SEC on February 21, 2020)
Underwriting Agreement, dated February 19, 2020, among the Company and BofA Securities, Inc., as representative of the underwriters named therein (Filed With SEC on February 21, 2020)
Underwriting Agreement, dated September 26, 2019, between the Company and BMO Capital Markets Corp., as representative of the underwriters named therein (Filed With SEC on September 27, 2019)
Open Market Sale Agreement, dated as of May 20, 2019, by and between BioXcel Therapeutics, Inc. and Jefferies LLC (Filed With SEC on May 20, 2019)